Effect of mouthrinses on Aggregatibacter actinomycetemcomitans biofilms in a hydrodynamic model

Clinical Oral Investigations

Volumn 14, Issue 3, 2010, Pages 241-250

  Sliepen, Isabelle ^a   van Essche, Mark ^a   Quirynen, Marc ^a   Teughels, Wim ^a  

^a CATHOLIC UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Aggregatibacter actinomycetemcomitans; Amine fluoride stannous fluoride mouthrinse; Biofilm; Chlorhexidine mouthrinse; Essential oil mouthrinse; Modified Robbins device

Indexed keywords

AMINE; CHLORHEXIDINE; DIAGNOSTIC AGENT; ESSENTIAL OIL; FLUORESCENT DYE; LISTERINE; MERIDOL; MOUTHWASH; SALICYLIC ACID DERIVATIVE; TERPENE; TIN FLUORIDE; TOPICAL ANTIINFECTIVE AGENT;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL COUNT; BIOFILM; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; DRUG COMBINATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INSTRUMENTATION; MATERIALS TESTING; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SEROTYPING; TIME;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; AMINES; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIOLOGICAL TECHNIQUES; BIOFILMS; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; DRUG COMBINATIONS; FLUORESCENT DYES; HUMANS; MATERIALS TESTING; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MOUTHWASHES; OILS, VOLATILE; POLYMERASE CHAIN REACTION; SALICYLATES; SEROTYPING; TERPENES; TIME FACTORS; TIN FLUORIDES;

EID: 77952425693     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-009-0286-0     Document Type: Article

References (55)

1. Botelho MA, Bezerra Filho JG, Correa LL, Fonseca SG, Montenegro D, Gapski R, Brito GA, Heukelbach J (2007) Effect of a novel essential oil mouthrinse without alcohol on gingivitis: a double-blinded randomized controlled trial. J Appl Oral Sci 15: 175-180.
2. Quirynen M, Papaioannou W, van Steenbergen TJ, Dierickx K, Cassiman JJ, van Steenberghe D (2001) Adhesion of Porphyromonas gingivalis strains to cultured epithelial cells from patients with a history of chronic adult periodontitis or from patients less susceptible to periodontitis. J Periodontol 72: 626-633.
3. Silverman S, Wilder R (2006) Antimicrobial mouthrinse as part of a comprehensive oral care regimen. Safety and compliance factors. J Am Dent Assoc 137: 22S-26S.
4. Mandell RL, Socransky SS (1981) A selective medium for Actinobacillus actinomycetemcomitans and the incidence of the organism in juvenile periodontitis. J Periodontol 52: 593-598.
5. Slots J (1999) Update on Actinobacillus Actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease. J Int Acad Periodontol 1: 121-126.
6. Overholt BF (1966) Actinobacillus actinomycetemcomitans endocarditis. Arch Intern Med 117: 99-102.
7. Muhle I, Rau J, Ruskin J (1979) Vertebral osteomyelitis due to Actinobacillus actinomycetemcomitans. JAMA 241: 1824-1825.
8. Martin BF, Derby BM, Budzilovich GN, Ransohoff J (1967) Brain abscess due to Actinobacillus actinomycetemcomitans. Neurology 17: 833-837.
9. Kinniment SL, Wimpenny JW, Adams D, Marsh PD (1996) The effect of chlorhexidine on defined, mixed culture oral biofilms grown in a novel model system. J Appl Bacteriol 81: 120-125.
10. Haase EM, Bonstein T, Palmer RJ Jr, Scannapieco FA (2006) Environmental influences on Actinobacillus actinomycetemcomitans biofilm formation. Arch Oral Biol 51: 299-314.
11. Ouhayoun JP (2003) Penetrating the plaque biofilm: impact of essential oil mouthwash. J Clin Periodontol 30(Suppl 5): 10-12.
12. Madlena M, Dombi C, Gintner Z, Banoczy J (2004) Effect of amine fluoride/stannous fluoride toothpaste and mouthrinse on dental plaque accumulation and gingival health. Oral Dis 10: 294-297.
13. Keijser JA, Verkade H, Timmerman MF, van der Weijden FA (2003) Comparison of 2 commercially available chlorhexidine mouthrinses. J Periodontol 74: 214-218.
14. Wolff LF (1985) Chemotherapeutic agents in the prevention and treatment of periodontal disease. Northwest Dent 64: 15-24.
15. Fine DH (1988) Mouthrinses as adjuncts for plaque and gingivitis management. A status report for the American Journal of Dentistry. Am J Dent 1: 259-263.
16. Arweiler NB, Boehnke N, Sculean A, Hellwig E, Auschill TM (2006) Differences in efficacy of two commercial 0. 2% chlorhexidine mouthrinse solutions: a 4-day plaque re-growth study. J Clin Periodontol 33: 334-339.
17. Busscher HJ, van der Mei HC (2006) Microbial adhesion in flow displacement systems. Clin Microbiol Rev 19: 127-141.
18. Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH (2005) Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS Immunol Med Microbiol 45: 191-199.
19. Bretz F, Genz A, Hothorn LA (2001) On the numerical availability of multiple comparison procedures. Biom J 43: 645-656.
20. Bergmans L, Moisiadis P, van Meerbeek B, Quirynen M, Lambrechts P (2005) Microscopic observation of bacteria: review highlighting the use of environmental SEM. Int Endod J 38: 775-788.
21. Cummins D, Creeth JE (1992) Delivery of antiplaque agents from dentifrices, gels, and mouthwashes. J Dent Res 71: 1439-1449.
22. McClanahan SF, Bartizek RD (2002) Effects of triclosan/copolymer dentifrice on dental plaque and gingivitis in a 3-month randomized controlled clinical trial: influence of baseline gingivitis on observed efficacy. J Clin Dent 13: 167-178.
23. Riep BG, Bernimoulin JP, Barnett ML (1999) Comparative antiplaque effectiveness of an essential oil and an amine fluoride/stannous fluoride mouthrinse. J Clin Periodontol 26: 164-168.
24. Arweiler NB, Netuschil L, Reich E (2001) Alcohol-free mouthrinse solutions to reduce supragingival plaque regrowth and vitality. A controlled clinical study. J Clin Periodontol 28: 168-174.
25. Charles CH, Mostler KM, Bartels LL, Mankodi SM (2004) Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol 3: 878-884.
26. Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C (1990) Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol 17: 575-579.
27. Larsen T (2002) Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol 17: 267-271.
28. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
29. Shapiro S, Giertsen E, Guggenheim B (2002) An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. Caries Res 36: 93-100.
30. Fine DH, Furgang D, Barnett ML (2001) Comparative antimicrobial activities of antiseptic mouthrinses against isogenic planktonic and biofilm forms of Actinobacillus actinomycetemcomitans. J Clin Periodontol 28: 697-700.
31. Larsen T, Fiehn NE (1995) Development of a flow method for susceptibility testing of oral biofilms in vitro. APMIS 103: 339-344.
32. Noiri Y, Okami Y, Narimatsu M, Takahashi Y, Kawahara T, Ebisu S (2003) Effects of chlorhexidine, minocycline, and metronidazole on Porphyromonas gingivalis strain 381 in biofilms. J Periodontol 74: 1647-1651.
33. Busscher HJ, Free RH, van Weissenbruch R, Albers FW, van der Mei HC (2000) Preliminary observations on influence of dairy products on biofilm removal from silicone rubber voice prostheses in vitro. J Dairy Sci 83: 641-647.
34. Sliepen I, van Essche M, Pauwels M, van Eldere J, Hofkens J, Quirynen M, Teughels W (2008) Colonization of hard and soft surfaces by Aggregatibacter actinomycetemcomitans under hydrodynamic conditions. Oral Microbiol Immunol 23: 498-504.
35. Sliepen I, Hofkens J, van Essche M, Quirynen M, Teughels W (2008) Aggregatibacter actinomycetemcomitans adhesion inhibited in a flow cell. Oral Microbiol Immunol 23: 520-524.
36. Bercy P, Lasserre J (2007) Susceptibility to various oral antiseptics of Porphyromonas gingivalis W83 within a biofilm. Adv Ther 24: 1181-1191.
37. Paraskevas S (2005) Randomized controlled clinical trials on agents used for chemical plaque control. Int J Dent Hyg 3: 162-178.
38. van Strydonck DA, Timmerman MF, van der Weijden GA (2005) Plaque inhibition of two commercially available chlorhexidine mouthrinses. J Clin Periodontol 32: 305-309.
39. Brecx M, Netuschil L, Reichert B, Schreil G (1990) Efficacy of Listerine, Meridol and chlorhexidine mouthrinses on plaque, gingivitis and plaque bacteria vitality. J Clin Periodontol 17: 292-297.
40. Netuschil L, Weiger R, Preisler R, Brecx M (1995) Plaque bacteria counts and vitality during chlorhexidine, Meridol and Listerine mouthrinses. Eur J Oral Sci 103: 355-361.
41. Brecx M, Brownstone E, MacDonald L, Gelskey S, Cheang M (1992) Efficacy of Listerine, Meridol and chlorhexidine mouthrinses as supplements to regular tooth cleaning measures. J Clin Periodontol 19: 202-207.
42. Gunsolley JC (2006) A meta-analysis of six-month studies of antiplaque and antigingivitis agents. J Am Dent Assoc 137: 1649-1657.
43. Stoeken JE, Paraskevas S, van der Weijden GA (2007) The long-term effect of a mouthrinse containing essential oils on dental plaque and gingivitis: a systematic review. J Periodontol 78: 1218-1228.
44. Fine DH, Furgang D, Schreiner HC, Goncharoff P, Charlesworth J, Ghazwan G, Fitzgerald-Bocarsly P, Figurski DH (1999) Phenotypic variation in Actinobacillus actinomycetemcomitans during laboratory growth: implications for virulence. Microbiol 145: 1335-1347.
45. Fine DH, Kaplan JB, Kachlany SC, Schreiner HC (2006) How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontol 2000(42): 114-157.
46. Zambon JJ, Slots J, Genco RJ (1983) Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease. Infect Immun 41: 19-27.
47. Okte E, Sultan N, Dogan B, Asikainen S (1999) Bacterial adhesion of Actinobacillus actinomycetemcomitans serotypes to titanium implants: SEM evaluation. A preliminary report. J Periodontol 70: 1376-1382.
48. Yang HW, Asikainen S, Dogan B, Suda R, Lai CH (2004) Relationship of Actinobacillus actinomycetemcomitans serotype b to aggressive periodontitis: frequency in pure cultured isolates. J Periodontol 75: 592-599.
49. Imbert-Bernard C, Valentin A, Reynes J, Mallie M, Bastide JM (1994) Relationship between fluconazole sensitivity of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count. Eur J Clin Microbiol Infect Dis 13: 711-716.
50. Abbott JD, Graves JF (1972) Serotype and sulphonamide sensitivity of meningococci isolated from 1966 to 1971. J Clin Pathol 25: 528-530.
51. van der Mei HC, White DJ, Atema-Smit J, Belt-Gritter E, Busscher HJ (2006) A method to study sustained antimicrobial activity of rinse and dentifrice components on biofilm viability in vivo. J Clin Periodontol 33: 14-20.
52. Inoue T, Shingaki R, Sogawa N, Sogawa CA, Asaumi J, Kokeguchi S (2003) Biofilm formation by a fimbriae-deficient mutant of Actinobacillus actinomycetemcomitans. Microbiol Immunol 47: 877-881.
53. Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB (2007) Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 86: 618-622.
54. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS (2002) Extracellular DNA required for bacterial biofilm formation. Science 295: 1487.
55. Fine DH, Markowitz K, Furgang D, Goldsmith D, Ricci-Nittel D, Charles CH, Peng P, Lynch MC (2007) Effect of rinsing with an essential oil-containing mouthrinse on subgingival periodontopathogens. J Periodontol 78: 1935-1942.